Literature DB >> 15714407

Candida glabrata endophthalmitis treated successfully with caspofungin.

Juan C Sarria1, Jay C Bradley, Ranya Habash, Kelly T Mitchell, Robert C Kimbrough, Ana M Vidal.   

Abstract

A 39-year-old man with Candida glabrata endophthalmitis was successfully treated with a 28-day course of intravenous caspofungin. Presence of underlying renal insufficiency and infection with a drug-resistant strain precluded use of amphotericin B or fluconazole. Intravitreal administration of antifungals and vitrectomy were not required. The role of caspofungin in Candida endophthalmitis is discussed.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15714407     DOI： 10.1086/427753

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  17 in total

Review 1.  Risk of Fungal Endophthalmitis Associated with Cataract Surgery: A Mini-Review.

Authors:  Tonya C Smith; Russell J Benefield; Jong Hun Kim
Journal:  Mycopathologia       Date:  2015-08-29       Impact factor: 2.574

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 3.  Treatment principles for Candida and Cryptococcus.

Authors:  Laura C Whitney; Tihana Bicanic
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-10       Impact factor: 6.915

4.  Penetration of topically administered 0.5-percent caspofungin eye drops into human aqueous humor.

Authors:  Chin Fen Neoh; Lok Leung; Anant Misra; Rasik B Vajpayee; Geoffrey E Davies; Robert O Fullinfaw; Kay Stewart; David C M Kong
Journal:  Antimicrob Agents Chemother       Date:  2011-01-24       Impact factor: 5.191

5.  Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives.

Authors:  M Kernt; A Kampik
Journal:  Clin Ophthalmol       Date:  2010-03-24

6.  In vitro susceptibilities of Candida spp. to caspofungin: four years of global surveillance.

Authors:  M A Pfaller; L Boyken; R J Hollis; S A Messer; S Tendolkar; D J Diekema
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

7.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

Review 8.  Etiological agents of fungal endophthalmitis: diagnosis and management.

Authors:  Rubens C Vilela; Luiza Vilela; Priscila Vilela; Raquel Vilela; Roberta Motta; Ana Paula Pôssa; Cirênio de Almeida; Leonel Mendoza
Journal:  Int Ophthalmol       Date:  2013-10-01       Impact factor: 2.031

9.  A Case of Candida albicans Endophthalmitis with No Predisposing Risk Factors and a Distant Source of Infection.

Authors:  Randhir Chavan; Mohammad Z Mustafa; Nirodhini Narendran; Shoaib Tarin; Yit Yang
Journal:  Case Rep Ophthalmol       Date:  2012-09-05

10.  Pharmacokinetics and pharmacodynamics of anidulafungin for experimental Candida endophthalmitis: insights into the utility of echinocandins for treatment of a potentially sight-threatening infection.

Authors:  J L Livermore; T W Felton; J Abbott; A Sharp; J Goodwin; L Gregson; P A Warn; S J Howard; W W Hope
Journal:  Antimicrob Agents Chemother       Date:  2012-10-31       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.